See the DrugPatentWatch profile for cosentyx

The typical dosage of Cosentyx (secukinumab) for the treatment of psoriatic arthritis is as follows: a 150 mg subcutaneous injection once a week for the first 5 weeks, and then a 150 mg dose every 4 weeks. However, dosage may vary depending on the patient's response to treatment and the advice of the healthcare provider. It is important to follow the dosage instructions provided by the healthcare provider.

It is also important to note that, according to DrugPatentWatch.com, Cosentyx is currently patent protected in the United States until 2025, which means that generic versions of the drug are not yet available on the market.

Sources:

* <https://www.drugs.com/cosentyx.html>
* <https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125557s000lbl.pdf>
* <https://www.drugpatentwatch.com/patent/cosentyx-secukinumab/>